Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Open House Drug Discount Agreements For The Active Ingredient Tiotropium Bromide Dosage Form Inhalation Solution Atc R03Bb04

Deadline: 01 Dec 2027

Germany

Ref. No.: 23081251

EMD:Ref Document

Bid Value: Ref Document

617 Days Left

Open House Drug Discount Agreements For The Active Ingredient Loperamide Atc A07Da03

Deadline: 01 Dec 2027

Germany

Ref. No.: 23080982

EMD:Ref Document

Bid Value: Ref Document

617 Days Left

Open House Drug Discount Agreements For The Active Ingredient Sulpiride Atc N05Al01

Deadline: 01 Dec 2027

Germany

Ref. No.: 23080338

EMD:Ref Document

Bid Value: Ref Document

617 Days Left

Open House Drug Discount Agreements For The Active Ingredient Fusidic Acid Atc D06Ax01

Deadline: 01 Dec 2027

Germany

Ref. No.: 23079730

EMD:Ref Document

Bid Value: Ref Document

617 Days Left

Open House Drug Discount Agreements For The Active Ingredient Repaglinide Atc A10Bx02

Deadline: 01 Dec 2027

Germany

Ref. No.: 23079491

EMD:Ref Document

Bid Value: Ref Document

617 Days Left

Open House Drug Discount Agreements For The Active Ingredients Lopinavir And Ritonavir Atc J05Ar10

Deadline: 01 Dec 2027

Germany

Ref. No.: 23079374

EMD:Ref Document

Bid Value: Ref Document

617 Days Left

Open House Drug Discount Agreements For The Active Ingredient Denosumab Atc M05Bx04

Deadline: 01 Dec 2027

Germany

Ref. No.: 23079280

EMD:Ref Document

Bid Value: Ref Document

617 Days Left

Open House Drug Discount Agreements For The Active Ingredient Lenograstim Atc L03Aa10

Deadline: 01 Dec 2027

Germany

Ref. No.: 23078095

EMD:Ref Document

Bid Value: Ref Document

617 Days Left

Open House Drug Discount Agreements For The Active Ingredient Glatiramer Acetate Prefilled Syringes Atc L03Ax13

Deadline: 30 Nov 2027

Germany

Ref. No.: 23077886

EMD:Ref Document

Bid Value: Ref Document

616 Days Left

Open House Drug Discount Agreements For The Active Ingredient Tiotropium Bromide Dosage Form Inhalation Solution Atc R03Bb04

Deadline: 31 Mar 2027

Germany

Ref. No.: 23076368

EMD:Ref Document

Bid Value: Ref Document

372 Days Left

Open House Drug Discount Agreements For The Active Ingredient Tiotropium Bromide Dosage Form Inhalation Solution Atc R03Bb04

Deadline: 30 Nov 2027

Germany

Ref. No.: 23074700

EMD:Ref Document

Bid Value: Ref Document

616 Days Left

Open House Drug Discount Agreements For The Active Ingredient Lenograstim Atc L03Aa10

Deadline: 30 Nov 2027

Germany

Ref. No.: 23072227

EMD:Ref Document

Bid Value: Ref Document

616 Days Left

Open House Drug Discount Agreements For The Active Ingredient Tiapride Atc N05Al03

Deadline: 01 Dec 2027

Germany

Ref. No.: 23072164

EMD:Ref Document

Bid Value: Ref Document

617 Days Left

Open House Drug Discount Agreements For The Active Ingredients Olmesartan And Hydrochlorothiazide Atc C09Da28

Deadline: 30 Nov 2027

Germany

Ref. No.: 23070181

EMD:Ref Document

Bid Value: Ref Document

616 Days Left

Open House Drug Discount Agreements For The Active Ingredient Tiapride Atc N05Al03

Deadline: 30 Nov 2027

Germany

Ref. No.: 23069731

EMD:Ref Document

Bid Value: Ref Document

616 Days Left

Showing 20611 to 20625 of 21570 results

‹
1
2
...
1372
1373
1374
1375
1376
1377
1378
...
1437
1438
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!